Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,030 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
Patel MR, Worthley SG, Stebbins A, Dill T, Rademakers FE, Valeti US, Barsness GW, Van de Werf F, Hamm CW, Armstrong PW, Granger CB, Kim RJ. Patel MR, et al. Among authors: granger cb. JACC Cardiovasc Imaging. 2010 Jan;3(1):52-60. doi: 10.1016/j.jcmg.2009.09.014. Epub 2010 Jan 12. JACC Cardiovasc Imaging. 2010. PMID: 20129531 Free article. Clinical Trial.
Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).
Patel MR, Pfisterer ME, Betriu A, Widmisky P, Holmes DR Jr, O'Neill WW, Stebbins A, Van de Werf F, Armstrong PW, Granger CB; APEX-AMI Investigators. Patel MR, et al. Among authors: granger cb. Am J Cardiol. 2009 Jan 15;103(2):181-6. doi: 10.1016/j.amjcard.2008.08.066. Epub 2008 Nov 7. Am J Cardiol. 2009. PMID: 19121433 Clinical Trial.
Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial.
Lopes RD, Elliott LE, White HD, Hochman JS, Van de Werf F, Ardissino D, Nielsen TT, Weaver WD, Widimsky P, Armstrong PW, Granger CB. Lopes RD, et al. Among authors: granger cb. Eur Heart J. 2009 Aug;30(16):2019-28. doi: 10.1093/eurheartj/ehp213. Epub 2009 Jun 6. Eur Heart J. 2009. PMID: 19502623 Free PMC article. Clinical Trial.
Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Jolicoeur EM, O'Neill WW, Hellkamp A, Hamm CW, Holmes DR Jr, Al-Khalidi HR, Patel MR, Van de Werf FJ, Pieper K, Armstrong PW, Granger CB; APEX-AMI Investigators. Jolicoeur EM, et al. Among authors: granger cb. Eur Heart J. 2009 Nov;30(21):2575-83. doi: 10.1093/eurheartj/ehp279. Epub 2009 Jul 11. Eur Heart J. 2009. PMID: 19596659 Clinical Trial.
Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Welsh RC, Granger CB, Westerhout CM, Blankenship JC, Holmes DR Jr, O'Neill WW, Hamm CW, Van de Werf F, Armstrong PW; APEX AMI Investigators. Welsh RC, et al. Among authors: granger cb. JACC Cardiovasc Interv. 2010 Mar;3(3):343-51. doi: 10.1016/j.jcin.2009.12.008. JACC Cardiovasc Interv. 2010. PMID: 20298996 Free article. Clinical Trial.
A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial.
Stebbins A, Mehta RH, Armstrong PW, Lee KL, Hamm C, Van de Werf F, James S, Toftegaard-Nielsen T, Seabra-Gomes R, White HD, Granger CB; Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI Investigators). Stebbins A, et al. Among authors: granger cb. Circ Cardiovasc Interv. 2010 Oct;3(5):414-22. doi: 10.1161/CIRCINTERVENTIONS.109.925180. Epub 2010 Sep 21. Circ Cardiovasc Interv. 2010. PMID: 20858863 Clinical Trial.
Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Mahaffey KW, Wampole JL, Stebbins A, Berdan LG, McAfee D, Rorick TL, French JK, Kleiman NS, O'Connor CM, Cohen EA, Granger CB, Armstrong PW; APEX-AMI Investigators. Mahaffey KW, et al. Among authors: granger cb. Contemp Clin Trials. 2011 Mar;32(2):178-87. doi: 10.1016/j.cct.2010.12.013. Epub 2011 Jan 8. Contemp Clin Trials. 2011. PMID: 21220052 Clinical Trial.
1,030 results